In the United States, premature ejaculation treatment is still a gap category because there is no FDA-approved oral prescription drug specifically indicated for PE. The American Urological Association guideline recommends several evidence-based options, including daily SSRIs, on-demand Clomipramine or Dapoxetine where available, and topical penile anesthetics as first-line pharmacologic approaches, although U.S. use of many oral options remains off-label.
FDA-approved medicines that may appear in PE care are usually approved for another purpose first. Lidocaine or lidocaine-prilocaine topical products are anesthetic medicines and may be used clinically to reduce penile sensitivity before intercourse, while SSRIs such as Sertraline, Paroxetine, or Fluoxetine are FDA-approved antidepressants sometimes prescribed off-label when PE is persistent and clinically distressing. This makes physician review important, since dosing, side effects, sexual-function effects, and drug interactions differ by product.
Priligy, the brand name for Dapoxetine, deserves separate attention because it was developed specifically as an on-demand PE medication rather than a daily antidepressant. Dapoxetine is a short-acting SSRI taken before sexual activity in countries where it is authorized, and published reviews describe it as an effective PE therapy with rapid absorption and a pharmacologic profile suited to intermittent use. In the U.S., however, Dapoxetine is not FDA-approved, and its application was rejected in 2005, so it is not dispensed through regular U.S. pharmacy channels as an approved PE drug.
Priligy (Dapoxetine)
Packs
Disclaimer
The information on this page is educational and should not be used as medical instruction. Speak with a licensed healthcare professional before purchasing or using any medicine, especially if you have health conditions or take other drugs.